Figure 5From: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer Manipulating miR-29b could counteract the effects of S100A7 on cell proliferation in MDA-MB-231 and MCF7. The proliferation of MDA-MB-231 and MCF7 cell lines were determined by MTT assay. (A, C) miR-29b levels of indicated cell lines. (B, D) MTT cell proliferation assays of indicated cell lines. (*p < 0.05, **p < 0.01).Back to article page